Figure legends
Figure 1. Characteristic analysis of AE reports in the FAERS and VigiAccess databases.
Figure 2. The ROR(A) and PRR(B) disproportionality analysis of signals at PTs level associated with pirfenidone in the FAERS database. ROR, reporting odds ratio; PRR, proportional reporting ratio; PTs, preferred terms; FAERS, Food and Drug Administration Adverse Event Reporting System; 95% CI, 95% credibility interval.
Figure 3. The ROR(A) and PRR(B) disproportionality analysis of signals at PTs level associated with nintedanib in the FAERS database. ROR, reporting odds ratio; PRR, proportional reporting ratio; PTs, preferred terms; FAERS, Food and Drug Administration Adverse Event Reporting System; 95% CI, 95% credibility interval.